project id: TCGA-STAD; case submitter id: TCGA-HF-7134; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.83; rna integrity number: 9.4; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IA; ajcc pathologic t: T1; ajcc staging system edition: 6th; classification of tumor: not reported; days to last follow up: 1588.0; icd 10 code: C16.2; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2008; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 0.8; longest dimension: 1.3; oct embedded: No; shortest dimension: 0.7; portion submitter id: TCGA-HF-7134-01A-11; percent necrosis: 0.0; percent neutrophil infiltration: 5.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 80.0;